Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Apr 26:10:909655.
doi: 10.3389/fcell.2022.909655. eCollection 2022.

Editorial: Targeting Bruton Tyrosine Kinase

Cornelia Brunner  1 , Annika C Betzler  1 , Jennifer R Brown  2 , Amy H Andreotti  3 , Emanuela Grassilli  4
Affiliations
Editorial

Editorial: Targeting Bruton Tyrosine Kinase

Cornelia Brunner et al. Front Cell Dev Biol. .
No abstract available

Keywords: B-cell neoplasia; BTK; autoimmune diseases; inflammation; innate and adaptive immune response; solid tumors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research TopicTargeting Bruton Tyrosine Kinase

References

    1. Eifert C., Wang X., Kokabee L., Kourtidis A., Jain R., Gerdes M. J., et al. (2013). A Novel Isoform of the B Cell Tyrosine Kinase BTK Protects Breast Cancer Cells from Apoptosis. Genes Chromosomes Cancer 52, 961–975. 10.1002/gcc.22091 - DOI - PMC - PubMed
    1. Giordano F., Vaira V., Cortinovis D., Bonomo S., Goedmakers J., Brena F., et al. (2019). p65BTK Is a Novel Potential Actionable Target in KRAS-mutated/EGFR-Wild Type Lung Adenocarcinoma. J. Exp. Clin. Cancer Res. 38, 260. 10.1186/s13046-019-1199-7 - DOI - PMC - PubMed
    1. Grassilli E., Pisano F., Cialdella A., Bonomo S., Missaglia C., Cerrito M. G., et al. (2016). A Novel Oncogenic BTK Isoform Is Overexpressed in colon Cancers and Required for RAS-Mediated Transformation. Oncogene 35, 4368–4378. 10.1038/onc.2015.5010.1038/onc.2015.504 - DOI - PMC - PubMed
    1. Kokabee L., Wang X., Sevinsky C. J., Wang W. L. W., Cheu L., Chittur S. V., et al. (2015). Bruton's Tyrosine Kinase Is a Potential Therapeutic Target in Prostate Cancer. Cancer Biol. Ther. 16, 1604–1615. 10.1080/15384047.2015.1078023 - DOI - PMC - PubMed
    1. Liu X., Pichulik T., Wolz O.-O., Dang T.-M., Stutz A., Dillen C., et al. (2017). Human Nacht, Lrr, and Pyd Domain-Containing Protein 3 (Nlrp3) Inflammasome Activity Is Regulated by and Potentially Targetable through Bruton Tyrosine Kinase. J. Allergy Clin. Immunol. 140, 1054–1067. e10. 10.1016/j.jaci.2017.01.017 - DOI - PubMed

Publication types

LinkOut - more resources